297 related articles for article (PubMed ID: 22702740)
1. Current and future management strategies for relapsed or progressive hepatoblastoma.
Venkatramani R; Furman WL; Fuchs J; Warmann SW; Malogolowkin MH
Paediatr Drugs; 2012 Aug; 14(4):221-32. PubMed ID: 22702740
[TBL] [Abstract][Full Text] [Related]
2. Surgery for hepatoblastoma in children.
Geiger JD
Curr Opin Pediatr; 1996 Jun; 8(3):276-82. PubMed ID: 8814407
[TBL] [Abstract][Full Text] [Related]
3. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation.
Tiao GM; Bobey N; Allen S; Nieves N; Alonso M; Bucuvalas J; Wells R; Ryckman F
J Pediatr; 2005 Feb; 146(2):204-11. PubMed ID: 15689909
[TBL] [Abstract][Full Text] [Related]
4. An update on diagnosis and treatment of hepatoblastoma.
Cao Y; Wu S; Tang H
Biosci Trends; 2024 Jan; 17(6):445-457. PubMed ID: 38143081
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of irinotecan single drug treatment in children with refractory or recurrent hepatoblastoma--a phase II trial of the childhood liver tumour strategy group (SIOPEL).
Zsíros J; Brugières L; Brock P; Roebuck D; Maibach R; Child M; Morland B; Casanova M; Pariente D; Paris C; de Camargo B; Ronghe M; Zimmermann A; Plaschkes J; Czauderna P; Perilongo G
Eur J Cancer; 2012 Dec; 48(18):3456-64. PubMed ID: 22835780
[TBL] [Abstract][Full Text] [Related]
6. Hepatoblastoma throughout SIOPEL trials - clinical lessons learnt.
Czauderna P
Front Biosci (Elite Ed); 2012 Jan; 4(1):470-9. PubMed ID: 22201887
[TBL] [Abstract][Full Text] [Related]
7. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
8. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
9. Current Approaches in Hepatoblastoma-New Biological Insights to Inform Therapy.
Wu PV; Rangaswami A
Curr Oncol Rep; 2022 Sep; 24(9):1209-1218. PubMed ID: 35438389
[TBL] [Abstract][Full Text] [Related]
10. Vincristine and irinotecan in children with relapsed hepatoblastoma: a single-institution experience.
Zhang YT; Feng LH; Zhong XD; Wang LZ; Chang J
Pediatr Hematol Oncol; 2015 Feb; 32(1):18-25. PubMed ID: 24852330
[TBL] [Abstract][Full Text] [Related]
11. Improved survival outcome for hepatoblastoma based on an optimal chemotherapeutic regimen--a report from the study group for pediatric solid malignant tumors in the Kyushu area.
Suita S; Tajiri T; Takamatsu H; Mizote H; Nagasaki A; Inomata Y; Hara T; Okamura J; Miyazaki S; Kawakami K; Eguchi H; Tsuneyoshi M;
J Pediatr Surg; 2004 Feb; 39(2):195-8; discussion 195-8. PubMed ID: 14966739
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of hepatoblastoma in the Indian context.
Arora RS
Indian Pediatr; 2012 Apr; 49(4):307-9. PubMed ID: 22080621
[TBL] [Abstract][Full Text] [Related]
13. Sustained Remission After Maintenance Irinotecan in Patient With Multiply Relapsed Hepatoblastoma.
Natarajan E; Auerbach C; Cheron R; Pashankar F
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e659-e661. PubMed ID: 31259823
[TBL] [Abstract][Full Text] [Related]
14. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
15. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
[TBL] [Abstract][Full Text] [Related]
16. Drug resistance in hepatoblastoma.
Warmann SW; Fuchs J
Curr Pharm Biotechnol; 2007 Apr; 8(2):93-7. PubMed ID: 17430157
[TBL] [Abstract][Full Text] [Related]
17. Successful nontransplant resection of POST-TEXT III and IV hepatoblastoma.
Lautz TB; Ben-Ami T; Tantemsapya N; Gosiengfiao Y; Superina RA
Cancer; 2011 May; 117(9):1976-83. PubMed ID: 21509775
[TBL] [Abstract][Full Text] [Related]
18. Strategy for hepatoblastoma management: Transplant versus nontransplant surgery.
Pimpalwar AP; Sharif K; Ramani P; Stevens M; Grundy R; Morland B; Lloyd C; Kelly DA; Buckles JA; de Ville De Goyet J
J Pediatr Surg; 2002 Feb; 37(2):240-5. PubMed ID: 11819207
[TBL] [Abstract][Full Text] [Related]
19. Treatment of hepatoblastoma: the North American cooperative group experience.
Malogolowkin MH; Katzenstein HM; Krailo M; Meyers RL
Front Biosci (Elite Ed); 2012 Jan; 4(5):1717-23. PubMed ID: 22201987
[TBL] [Abstract][Full Text] [Related]
20. Relapsed hepatoblastoma.
Trobaugh-Lotrario AD; Feusner JH
Pediatr Blood Cancer; 2012 Nov; 59(5):813-7. PubMed ID: 22648963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
